This study resolves the heterogeneity of smooth muscle cells (SMCs) in aortic dissection at single-cell resolution, revealing the critical roles of SMC subpopulations in fibrosis, inflammation, and thrombosis. It provides new insights into the mechanistic understanding and potential intervention strategies for vascular diseases.
Literature Overview
The article titled "Single‐cell transcriptomics reveals cellular heterogeneity and phenotypic transitions of smooth muscle cells in aortic dissection," published in the journal iMeta, systematically investigates the transcriptomic heterogeneity of smooth muscle cells (SMCs) in aortic dissection (AD) and their functional contributions to disease progression. By integrating single-cell RNA sequencing (scRNA-seq) with functional experiments, the study uncovers distinct programs of SMC subpopulations in fibrosis, inflammation, and intercellular communication, and links thrombotic status to specific phenotypic transitions. Furthermore, it proposes that molecules such as ANGPTL4, VEGFA, and PLOD2 may serve as potential therapeutic targets, broadening our understanding of AD pathogenesis.Background Knowledge
Aortic dissection (AD) is a life-threatening vascular emergency characterized by dysfunction of medial smooth muscle cells (SMCs) and degradation of the extracellular matrix (ECM). Current studies on SMC phenotypic switching are largely limited to bulk transcriptomic analyses, which fail to resolve internal heterogeneity. Although pathways such as TGF-β and NF-κB are known to be involved in SMC dedifferentiation, the precise mechanisms driving specific pathological phenotypes (e.g., pro-fibrotic or pro-inflammatory) remain unclear. The advent of single-cell technologies offers new tools to dissect SMC heterogeneity. This study capitalizes on this opportunity to systematically map the subpopulation architecture of SMCs in AD, revealing functional specialization among subpopulations in thrombosis, vascular remodeling, and immune regulation, thus providing a novel perspective on vascular homeostasis imbalance.
Research Methods and Experiments
The authors performed scRNA-seq on lesion tissues from 10 AD patients (with and without thrombus) and paired adjacent normal aortic tissues from 5 patients, analyzing a total of 145,660 cells. Using UMAP clustering and canonical marker genes, they identified four major cell types, focusing on the SMC population to define five transcriptionally distinct SMC subpopulations (SMC1–5). Functional programs and differentiation trajectories of each subpopulation were analyzed using GO, GSEA, and pseudotime trajectory inference. Cell-cell interaction networks were explored via CellChat, and key signaling pathways were validated through in vitro co-culture, Transwell migration assays, Western blotting, and immunofluorescence. This integrated approach enabled a complete pipeline from discovery of heterogeneity to mechanistic validation.Key Conclusions and Perspectives
Research Significance and Prospects
This study identifies several potential therapeutic targets for drug development; for example, targeting the SMC2-ECM axis or the SMC3-inflammation axis may suppress vascular remodeling and inflammatory amplification. Clinically, the proportions of SMC subpopulations or plasma levels of ANGPTL4 could serve as biomarkers for disease activity or thrombotic risk. For disease modeling, future work may involve generating animal models with reporter genes specific to distinct SMC phenotypes to dynamically track phenotypic transitions, enhancing the spatiotemporal resolution of mechanistic studies.
Conclusion
This study leverages single-cell transcriptomics to deeply dissect the heterogeneity and dynamic phenotypic transitions of smooth muscle cells in aortic dissection, uncovering the functional specialization of SMC subpopulations in fibrosis, inflammation, and thrombosis. It not only deepens our understanding of the pathological mechanisms of aortic dissection but also offers new avenues for clinical intervention. From bench to bedside, these findings may facilitate precision classification based on SMC phenotypes to guide individualized therapies. For instance, targeting ANGPTL4 or VEGFA may modulate the immune microenvironment and vascular permeability, while inhibiting PLOD2 or MAPK pathways could slow ECM remodeling and inflammatory progression. Moreover, dynamic monitoring of SMC states may become a valuable tool for assessing disease progression and treatment response. This work lays a solid foundation for building more precise disease models and developing novel biomarkers, marking a significant step toward a mechanism-driven approach in aortic disease care.
